Journal article
Dexamethasone-eluting cochlear implants reduce inflammation and foreign body response in human and murine cochleae
Scientific reports, Vol.15(1), 30615
08/20/2025
DOI: 10.1038/s41598-025-10739-y
PMCID: PMC12368128
PMID: 40836064
Abstract
The inflammatory foreign body response (FBR) following cochlear implantation (CI) can negatively impact CI outcomes, including increased electrode impedances. This study aims to investigate the long-term efficacy of dexamethasone-eluting cochlear implant and locally delivered dexamethasone, a potent anti-inflammatory glucocorticoid, on the intracochlear FBR and electrical impedance post-implantation in a murine model. Preliminary impedance data in humans are also provided as a complement to the murine data to illustrate generalizability and reinforce implications related to clinical application. The left ears of CX3CR1
+/GFP
Thy1
+/YFP
(macrophage-neuron dual reporter) mice were implanted with dexamethasone-eluting cochlear implants (Dex-CI) or standard implant (Standard-CI) while the right ear served as unoperated control. Another group of dual reporter mice was implanted with a standard CI electrode array followed by injection of dexamethasone in the middle ear to mimic current clinical practice (Dex-local). Mouse implants were electrically stimulated with serial measurements of electrical impedance. Human subjects were implanted with either standard or Dex-CI followed by serial impedance measurements. Dex-CI reduced electrical impedance in the murine model and human subjects and inflammatory FBR in the murine model for an extended period. Dex-local in the murine model is ineffective for long-term reduction of FBR and electrode impedance. Our data suggests that dexamethasone-eluting arrays are more effective than the current clinical practice of locally applied dexamethasone in reducing FBR and electrical impedance.
Details
- Title: Subtitle
- Dexamethasone-eluting cochlear implants reduce inflammation and foreign body response in human and murine cochleae
- Creators
- Muhammad Taifur Rahman - Iowa City, IA 52242 USABrian J Mostaert - Iowa City, IA 52242 USAPeter Eckard - Iowa City, IA 52242 USAShakila Mahmuda Fatima - Iowa City, IA 52242 USARachel Scheperle - Iowa City, IA 52242 USAIbrahim Razu - Iowa City, IA 52242 USABryce Hunger - Iowa City, IA 52242 USARafal T. Olszewski - Bethesda, MD USAShoujun Gu - Bethesda, MD USACristina L. Garcia - Iowa City, IA 52242 USANashwaan Ali Khan - Iowa City, IA 52242 USADouglas M Bennion - Iowa City, IA 52242 USAJacob Oleson - University of Iowa, BiostatisticsJonathon R. Kirk - Sydney, AustraliaYa Lang Enke - Sydney, AustraliaRobert D. Gay - Sydney, AustraliaRobert J. Morell - Bethesda, MD USAKeiko Hirose - St. Louis, MO USAMichael Hoa - Bethesda, MD USAAlexander D. Claussen - Iowa City, IA 52242 USAMarlan R. Hansen - Iowa City, IA 52242 USA
- Resource Type
- Journal article
- Publication Details
- Scientific reports, Vol.15(1), 30615
- DOI
- 10.1038/s41598-025-10739-y
- PMID
- 40836064
- PMCID
- PMC12368128
- NLM abbreviation
- Sci Rep
- ISSN
- 2045-2322
- eISSN
- 2045-2322
- Publisher
- Nature Publishing Group UK
- Grant note
- National Institute on Deafness and Other Communication DisordersMadeline Pyle (Auditory Development and Restoration Program, Neurotology Branch, National Institute on Deafness and Other Communication Disorders)
The authors thank Kapila de Silva (Cochlear Limited) for his technical support for UPLC experiments for dexamethasone-eluting implants from the murine model. The authors are grateful to Amy Bussa (Department of Otolaryngology-Head and Neck Surgery, The University of Iowa, Iowa City, IA, United States) for her dependability in sending notifications and email reminders to subjects regarding the daily remote impedance measurements. Authors would also like to acknowledge Madeline Pyle (Auditory Development and Restoration Program, Neurotology Branch, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, MD, United States) for her work in streamlining our immune cell scRNA-Seq protocol.
- Language
- English
- Date published
- 08/20/2025
- Academic Unit
- Communication Sciences and Disorders; Molecular Physiology and Biophysics; Iowa Neuroscience Institute; Biostatistics; Neurosurgery; Otolaryngology
- Record Identifier
- 9984948118302771
Metrics
27 Record Views